Most double-stranded DNA (dsDNA) bacteriophages and animal viruses share common features in DNA replication as well as DNA maturation. DNA replication in many dsDNA bacteriophage systems results in the formation of a large headto-tail concatemeric complex composed of tandem repeats of the viral genome, which is subsequently cleaved into unitlength monomers and packaged into preformed capsid precursors, with a concomitant loss of scaffolding proteins (7, 8, 10, 13) . Both biochemical and genetic approaches have been exploited extensively for studies of dsDNA bacteriophage systems. Many protein components of the DNA cleavage and packaging machinery have been identified (11, 25, 27) . All DNA cleavage and packaging systems identified to date contain a two-subunit terminase complex which binds and cleaves viral DNA, a translocase activity which is responsible for translocation of DNA into the capsid, with the consumption of ATP, and a scaffolding-protein-containing prohead in which portal proteins form a dodecameric ring at a portal vertex through which DNA is taken in (reviewed in reference 10).
Herpes simplex virus type 1 (HSV-1) contains a 152-kb dsDNA genome composed of two covalently linked unique regions (U L and U S ), flanked by inverted repeats (45, 50) (Fig.  1) . During DNA replication, the two unique regions U L and U S invert with respect to each other, presumably through a generalized recombination mechanism within the repeated regions of the genome, generating four isomeric forms of progeny viruses (14, 28, 47, 50) . DNA replication is thought to result in the formation of large head-to-tail DNA concatemers (9, 29, 30) , which are cleaved at specific sites within the a sequences into unit-length monomeric genomes and packaged into preassembled capsids, with loss of scaffolding proteins (18, 38, 54, 56) .
Three types of intracellular capsids have been identified in HSV-1-infected cells by sucrose gradient sedimentation: A (empty), B (intermediate), and C (full) (16, 20, 40, 46) . A and C capsids have similar protein compositions, but only C capsids contain viral DNA. B capsids were initially thought to be analogous to phage proheads in that B capsids contain a scaffolding protein (designated VP22a, encoded by the UL26.5 gene) which is lost from capsids when DNA is packaged. However, in a cell-free capsid assembly system, Newcomb and colleagues (39) recently found a spherical, unstable capsid intermediate with a protein composition similar to that of B capsids. They proposed that these less angular and more open structures rather than B capsids are authentic procapsid intermediates (39) . Although B capsids may be a dead-end product of the capsid maturation process, they represent the most closely related stable structures to procapsids that can be isolated. Thus, procapsids are thought to be precursors to DNA-containing C capsids, and empty A capsids are thought to result from abortive attempts at DNA encapsidation (39, 43) . Temperature-sensitive mutants whose mutations map within six HSV-1 genes, UL6, UL15, UL25, UL28, UL32, and UL33, are defective in DNA cleavage and packaging and in production of A and C capsids (1-3, 6, 44, 51, 52, 58) . The involvement of at least six genes suggests that HSV DNA cleavage and packaging is a complex process.
The UL15 gene composed of two exons is one of only a few spliced genes in the HSV-1 genome and is predicted to encode a 735-amino-acid (aa) protein (15, 19) . UL15 is highly conserved among the herpesvirus family, and sequence analysis indicates a possible homology between the UL15 protein of HSV-1 and the large subunit (gp17) of the terminase complex of bacteriophage T4 (17) . The most significant aspect of this homology is the presence of a putative nucleotide binding fold (Walker boxes A and B) in both proteins (19, 57) , suggesting that UL15 may be able to bind and hydrolyze ATP as has been demonstrated for gp17 and other phage terminases (5, 10, 12) .
A temperature-sensitive mutant (ts66.4) bearing a lesion in the second exon of the UL15 gene has been isolated and shown to be defective in DNA cleavage and packaging (6, 44) . However, temperature-sensitive mutants are prone to problems associated with incomplete penetrance (leak), tendency to revert to wild type, and potential transdominant interference of wild-type protein function by the presence of a quasi-stable yet nonfunctional mutant protein at the nonpermissive temperature. In this report, we describe the isolation and characterization of UL15 insertional mutants in which an ICP6::lacZ cassette is inserted into either the first or the second exon of the UL15 gene. We show that although two UL15 mutants are able to undergo wild-type levels of DNA replication and genomic inversion, they are defective in DNA cleavage and packaging. Furthermore, we find that two proteins with molecular masses of 81 and 30 kDa are translated separately from the UL15 gene and that the 81-kDa full-length UL15 protein is required for DNA cleavage and packaging.
MATERIALS AND METHODS

Cells and viruses.
African green monkey kidney cells (Vero; American Type Culture Collection, Rockville, Md.) were propagated and maintained as described previously (59) . Cell lines M-3, C-2, and G-27, which are permissive for UL15 mutants (see below), were propagated as described above, but with the addition of 100 g of the antibiotic G418 (geneticin, a neomycin analog; GIBCO Laboratories, Grand Island, N.Y.) per ml of medium. The KOS strain of HSV-1 was used as the wild-type virus as well as the parental virus for the isolation of UL15 insertion mutants hr81-1 and hr81-2. A temperature-sensitive mutant defective in the UL15 gene at the nonpermissive temperature (39.5ЊC), ts66.4, a kind gift from B. Roizman (University of Chicago), was propagated at 34ЊC and used to screen candidate UL15-permissive cell lines at 39.5ЊC.
Plasmids and bacteria. Plasmid pUC-H3UL15G was made by cloning the HindIII J fragment of HSV-1 KOS strain (nucleotides [nt] 28038 to 39849) (37) into the HindIII site of the vector pUC119. This HindIII J fragment contains the 5Ј-terminal portion of the UL13, UL14, the first exon of UL15, UL16, UL17, the second exon of UL15, UL18, and the promoterless 3Ј-terminal part of UL19 genes.
pUC-UL15E1LacZS, containing the disrupted first exon of UL15, and pUCUL15E2LacZS, containing the disrupted second exon of UL15, were constructed as follows. pUC-UL15E1 contains the SacI/SphI fragment spanning the first exon of UL15 cloned into SacI/SphI sites of the pUC119 vector. pUC-UL15E1 was partially digested with XmnI, and the linearized plasmid was gel purified. The 4.3-kb BamHI fragment containing the lacZ gene under the control of the ICP6 promoter (ICP6::lacZ cassette) (23) was filled in with Klenow enzyme and ligated to the linearized plasmid pUC-UL15E1. The resultant construct, which contains the ICP6::lacZ cassette inserted at the XmnI site (corresponding to amino acid residue 153) within the first exon of UL15, was designated pUC-UL15E1LacZS. The SacI/SphI fragment containing the second exon of UL15 was ligated to the SacI/SphI sites of pUC119 to generate pUC-UL15E2. pUC-UL15E2LacZS was made by inserting the BamHI fragment of ICP6::lacZ cassette into the BamHI site of pUC-UL15E2 at a position corresponding to amino acid residue 509 of UL15. In both pUC-UL15E1LacZS and pUC-UL15E2LacZS, the transcriptional orientation of the lacZ gene was same as that of the UL15 gene.
Plasmids pT7ApoUL15G, containing the UL15 genomic DNA, and pT7ApoUL15C, containing the UL15 cDNA, were constructed as follows. Plasmid pUC-H3UL15G was partially digested with ApoI. The ApoI fragment containing the UL15 locus (nt 28680 to 35009 [37] ) was isolated and subcloned into the EcoRI site of pBluescriptIISKϩ (Stratagene, La Jolla, Calif.) to generate pT7ApoUL15G. To construct the UL15 cDNA, the splice junction of UL15 exons 1 and 2 (15) was generated by PCR, using HSV-1 KOS-infected (13 h, multiplicity of infection [MOI] of 3) Vero cell RNA. Poly(A) ϩ RNA was isolated, and 2.5 g was used in reverse transcription-PCR, using commercial kits as described by the manufacturer (Fast Track and cDNA Cycle kits; Invitrogen, San Diego, Calif.). PCR primer oligonucleotides were 5Ј-CTCGTTTCCGGAC GGGTCGC-3Ј in exon 1 and 5Ј-GGCCTCGTCGACAAAGAGCAGG-3Ј in exon 2, corresponding to nt 29991 to 30010 and 33679 to 33658, respectively. These oligonucleotides contained the BspEI (nt 29992) and SalI (nt 33688) sites spanning the UL15 intron. The 91-nt BspEI/SalI-digested PCR product was cloned into the BspEI/SalI sites to replace the intron in pT7ApoUL15G; the resultant plasmid, pT7ApoUL15C, contains only the UL15 cDNA. Nucleotide sequence analysis of the PCR product confirmed the sequence as reported previously (37) .
Plasmids pCMV-UL15C and pCMV-UL15G, which contain the UL15 cDNA or genomic DNA under the control of the constitutive cytomegalovirus immediate-early (CMV-IE) promoter, were constructed as follows. Either pT7ApoUL15C or pT7ApoUL15G was digested with HindIII/XbaI, and a gelpurified 2.8-kb fragment containing the UL15 cDNA from pT7ApoUL15C or a 6.4-kb fragment containing the UL15 genomic DNA from pT7ApoUL15G was ligated into the HindIII/XbaI sites of the expression vector pCDNAI/Amp, containing the CMV-IE promoter (Invitrogen), to construct pCMV-UL15C or pCMV-UL15G, respectively.
All recombinant plasmids were propagated in Escherichia coli DH5␣ by standard procedures (34) .
Isolation of UL15 cell lines. To isolate cell lines which are permissive for UL15 mutants, 1.5 ϫ 10 6 freshly trypsinized exponentially growing Vero cells were cotransfected with 2 g of pSV2neo and 18 g of either pT7ApoUL15G, pT7ApoUL15C, or pUC-H3UL15G as described previously (22, 24) and grown in medium containing 1 mg of G418 per ml. The G418 concentration was decreased to 0.5 mg/ml after 5 days. Two weeks after cotransfection, individual G418-resistant cells were picked and screened for the ability to support the growth of ts66.4 at the nonpermissive temperature (39.5ЊC).
Construction of UL15 insertional mutants by marker transfer. Marker transfer experiments were carried out as described previously (21) . In brief, either XmnI/HindIII-linearized pUC-UL15E1LacZS or pUC-UL15E2LacZS plasmid and infectious KOS DNA were used in a molar ratio of 10:1 to transfect 1.5 ϫ 10 6 freshly trypsinized exponentially growing UL15-permissive cells. When maximum cytopathic effect was observed, progeny viruses were collected, titers were determined on M-3 cells, and 2,500 infectious viral particles were plated onto 50 100-mm-diameter plates containing an M-3 cell monolayer. The resultant plaques were stained with neutral red in the presence of the chromogenic substrate 5-bromo-4-chloro-3-indolyl-␤-D-galactoside (X-Gal). The plaques with blue color were selected and plaque purified three times on M-3 cells before stocks were prepared.
Transient complementation assay. The transient complementation assay was carried out as described previously (36) . In brief, 1.5 ϫ 10 6 freshly trypsinized exponentially growing Vero cells were transfected with 8 g of either pCDNAI/ Amp, pCMV-UL15C, or pCMV-UL15G. At 24 h posttransfection, cells were superinfected with either hr81-1 or hr81-2 at an MOI of 1 PFU per cell. At 24 h postinfection, progeny viruses were harvested and assayed on the M-3 cell line for total yield.
Generation of anti-UL15 (␣-UL15) polyclonal antiserum. Rabbit polyclonal antiserum similar to that previously described (6) was generated against the UL15 exon 2 sequences. A HincII/XbaI fragment was isolated from subclone pT7ApoUL15G as described above and cloned into the StuI/XbaI sites of the pMal-C vector (New England Biolabs, Beverly, Mass.). This clone encoded the maltose binding protein (MBP) fused to the C-terminal 351 aa of UL15. Fusion protein was expressed and purified as instructed by the vector manufacturer. Five hundred micrograms of purified antigen was mixed with complete Freund's adjuvant and inoculated intramuscularly into New Zealand White rabbits. Booster immunizations of antigen in incomplete Freund's adjuvant were performed every 4 weeks for 10 months. Serum from one rabbit, AS9, was collected by standard protocols and used as described in Results.
Western blot analysis. To analyze infected cell lysates, 3 ϫ 10 6 cells in a 100-mm-diameter tissue culture dish were infected with virus stocks at an MOI of 10 PFU per cell at 37ЊC. Cells were collected at 14 h postinfection by centrifugation at 2,000 rpm for 10 min and rinsed with phosphate-buffered saline (137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 6 freshly trypsinized exponentially growing Vero cells were transfected with 8 g of expression plasmids as described previously (21) and plated on a 60-mm-diameter tissue culture dish for 24 h, and cell lysates were prepared and resuspended in 50 l of 1ϫ SDS-PAGE loading buffer as described above. Cell lysates in SDS-PAGE loading buffer were heated at 95ЊC for 5 min and vortexed vigorously for 30 s, and 20-l aliquots of samples were subjected to electrophoresis on an SDS-10% polyacrylamide gel. ECL (enhanced chemiluminescence) Western blotting analysis was performed as instructed by the manufacturer (Amersham, Buckinghamshire, England). To detect the UL15 gene products, the ␣-UL15 rabbit polyclonal antibody was used as the primary antibody at a dilution of 1:2,000 (in 5% nonfat milk in phosphate-buffered saline containing 0.2% Tween 20) to hybridize with the membrane at 4ЊC overnight. Protein quantification analysis was performed as suggested by the manufacturer, using bands which were in the linear response range.
DNA isolation and analysis by Southern blotting and PFGE. Intact infectious viral genomic DNA used in marker transfer experiments was isolated as described previously (62) . Total viral DNA and cellular DNA used in Southern blot analysis were isolated as described previously (61) . For Southern blot analysis, cellular or viral DNA was digested with appropriate restriction endonucleases, subjected to conventional agarose gel electrophoresis or pulsed-field gel electrophoresis (PFGE), blotted to Gene Screen Plus nylon membranes (New England Nuclear Corp., Boston, Mass.), hybridized with 32 P-labeled specific probes, and visualized by autoradiography as instructed by the manufacturer. DNA probes were prepared by labeling desired gel-isolated restriction fragments by using a Random Primed DNA Labeling kit (Boehringer Mannheim, Indianapolis, Ind.). Preparation and analysis of encapsidated viral DNA and PFGE were carried out as described previously (35, 49) .
Analysis of viral capsids. HSV-1 capsids were isolated by using a modification of a method developed by Sherman and Bachenheimer (52) . Cells were infected at an MOI of 10 PFU per cell at 37ЊC. At 20 h postinfection, cells were collected by 4,000-rpm centrifugation at 4ЊC for 15 min, rinsed with Tris-buffered saline, resuspended in phosphate buffer (40 mM sodium phosphate buffer [pH 7.4], 0.15 M NaCl, 1 mm EDTA, 1 mm EGTA, 1 mm phenylmethylsulfonyl fluoride, 5 g of pepstatin A per ml, 5 g of leupeptin per ml) with 1% Nonidet P-40, incubated on ice for 30 min, and probe sonicated for 30 s. The cell lysate was layered onto a 15 to 50% (wt/wt in phosphate buffer) sucrose gradient and centrifuged at 35,000 rpm for 30 min at 4ЊC (with an SW50.1 or SW41 rotor). Capsids were visualized by light scattering upon illumination with a halogen fiber-optic lamp.
RESULTS
Isolation of UL15-containing permissive cell lines and UL15 mutants. Permissive cell lines containing the UL15 gene were isolated for the propagation of UL15 mutants. Vero cells were cotransfected with a plasmid conferring neomycin resistance (pSV2neo) and a plasmid containing either the UL15 cDNA (pT7ApoUL15C) or the UL15 genomic DNA (pT7ApoUL15G, containing the UL15, UL16, and UL17 genes, or pUC-H3UL15G, containing the 5Ј-terminal portion of the UL13, UL14, UL15 exon 1, UL16, UL17, UL15 exon 2, UL18, and the promoterless 3Ј-terminal portion of the UL19 genes) (Fig.  1) . G418-resistant cells were screened for the ability to support the growth of the temperature-sensitive UL15 mutant ts66.4 at the nonpermissive temperature (39.5ЊC). Ten such cell lines were isolated, and Southern analysis revealed that the copy number of integrated UL15 genes per cell ranged from 20 to 500 (data not shown). Three cell lines were chosen for further study; M-3 cells contain the larger genomic fragment (pUC-H3UL15G), G-27 cells contain the smaller genomic fragment (pT7ApoUL15G), and C-2 cells contain the cDNA fragment (pT7ApoUL15C).
Viral mutants bearing the inactivated UL15 gene were constructed by marker transfer. The UL15-complementing cell lines, M-3, G-27, and C-2, were cotransfected with infectious KOS DNA and a mutant UL15 gene-containing plasmid, either pUC-UL15E1LacZS (exon 1 insertion) or pUCUL15E2LacZS (exon 2 insertion). Homologous recombination between KOS DNA and these mutant plasmids would be expected to generate recombinant viruses which contain the ICP6::lacZ cassette inserted either in UL15 exon 1 (at residue 153) or in UL15 exon 2 (at residue 509). Progeny viruses were plated on M-3 cells, and blue plaques were isolated, purified, and propagated. Independent plaques resulting from marker transfer with pUC-UL15E1LacZS (hr81-1) and pUCUL15E2LacZS (hr81-2) were isolated. To confirm that hr81-1 and hr81-2 contain the ICP6::lacZ cassette at the appropriate positions, total DNA from the cells infected with KOS, hr81-1 or hr81-2 was digested with XhoI and subjected to Southern blot hybridization using either the 32 P-labeled EcoRI lacZ fragment or the 32 P-labeled UL15 cDNA AflII/MluI fragment as a probe as described in the legend to Fig. 2 . The lacZ probe would be expected to detect a 5.7-kb fragment in hr81-1 and a 3.8-kb fragment in hr81-2 ( Fig. 2A, lanes 3, 4, 7, and 8 ). When the membrane was hybridized with the UL15 cDNA probe, 4.8-, 2.8-, and 2.5-kb XhoI fragments would be expected in KOS DNA (Fig. 2B, lanes 2 and 6) . However, since the inserted ICP6::lacZ cassette contains one XhoI recognition site, hr81-1 would be expected to contain 5.7-and 1.4-kb fragments instead of the 2.8-kb fragment, while hr81-2 was expected to contain 3.8-and 2.9-kb fragments instead of the 2.5-kb frag-ment present in KOS DNA (Fig. 2B, lanes 3, 4, 7 , and 8). Figure 2 clearly demonstrates all of the expected bands, thus indicating that the ICP6::lacZ cassette was inserted into the expected sites in both hr81-1 and hr81-2.
Phenotypic analysis of hr81-1 and hr81-2. To determine if UL15 is essential for viral growth, hr81-1 and hr81-2 were tested for plaque-forming ability on Vero, C-2, G-27, and M-3 cell lines. Both mutants were unable to form plaques on Vero cells but were able to do so on either C-2, G-27, or M-3 cells at similar efficiencies (Table 1) . Since the C-2 cell line contains only the UL15 cDNA, this result indicates that growth defects in hr81-1 and hr81-2 are within the UL15 gene and that the UL15 gene is essential for viral growth. A transient complementation assay further confirms that growth defects in hr81-1 and hr81-2 were due to loss of UL15 gene function. Vero cells were transfected with expression constructs in which either the UL15 cDNA (pCMV-UL15C) or the UL15 genome DNA (pCMV-UL15G) was under the control of a constitutive CMV-IE promoter; the transfected cells were superinfected with the UL15 mutant viruses. Table 2 shows that cells transfected with pCMV-UL15G and pCMV-UL15C could support the growth of both hr81-1 and hr81-2 whereas cells transfected with the control plasmid (pCDNAI/Amp) could not. Taken together, these results indicate that growth defects in hr81-1 and hr81-2 result from loss of the essential UL15 gene.
The abilities of hr81-1 and hr81-2 to express UL15 proteins were determined by Western blot analysis. Total cell extracts from infected cells were prepared and assessed for the presence of UL15 gene products by using an ␣-UL15 polyclonal antibody raised against an MBP-UL15 exon 2 fusion protein as described in Materials and Methods. The following observations were made. (i) In the KOS-infected Vero cell extract, there was a band of 81 kDa ( Fig. 3A and B, lanes 2) which was absent in both hr81-1-and hr81-2-infected Vero cells ( Fig. 3A and B, lanes 3 and 4). The size of this band was consistent with the predicated molecular mass of 81 kDa for the full-length UL15 protein of 735 aa. When M-3 cells were infected with either hr81-1 or hr81-2, the 81-kDa band was detected ( Fig. 3A and B, lanes 7 and 8), indicating that expression of the fulllength UL15 protein in the cell line could be induced by viral infection. The 81-kDa band was also detected in the extract from Vero cells transfected with expression plasmid pCMV-UL15G or pCMV-UL15C (Fig. 3A and B, lanes 10 and 11), whereas this band was absent in the extract from Vero cells transfected with the control plasmid pCDNAI/Amp (Fig. 3A and B, lanes 9). Thus, these results confirm that the 81-kDa band is the authentic full-length product of the UL15 gene.
(ii) Since hr81-2 contains the ICP6::lacZ cassette inserted at amino acid residue 509, it might be expected that a 59-kDa truncated derivative of the UL15 protein lacking its 226 C-terminal amino acid residues would still be expressed (Fig. 1) . In fact, in hr81-2-infected cells, the predicted 59-kDa band was detected ( Fig. 3A and B, lanes 4 and 8) . The inability of the truncated UL15 protein to support viral growth indicates that the C terminus of the full-length UL15 protein is essential. Since the ICP6::lacZ cassette is inserted at aa 153 in hr81-1, it might be expected that the 153-aa C-terminally truncated UL15 protein with the predicted molecular mass of 20 kDa would be expressed as well; however, this product would not be detected by the antibody which was raised against the second exon of a Vero cells were transfected with the indicated plasmid and superinfected with either hr81-1 or hr81-2 as described in Materials and Methods. Progeny virus was titered on M-3 cells. This experiment was repeated three times, and similar results were obtained each time.
b Complementation index (CI) is calculated as PFU of progeny virus from cultures transfected with the indicated plasmid/PFU of progeny virus from mocktransfected cultures.
UL15. (iii)
The ␣-UL15 antibody specifically recognized a 30-kDa protein in KOS-infected cells (Fig. 3B, lanes 2 and 6) , which was consistent with the observation by Baines et al. that UL15 encodes two proteins with molecular masses of 75 and 35 kDa (6). However, more interestingly, we found that hr81-1 was still able to express the 30-kDa protein whereas hr81-2 failed to express either the 81-or 30-kDa protein (Fig. 3B,  lanes 3 and 4) . Both mutants as well as KOS were able to express the 30-kDa UL15 protein on M-3 cells (Fig. 3B, lanes  6 to 8) . Quantification of the 30-kDa protein bands indicated that the levels of 30-kDa protein expressed in hr81-1-infected Vero cells were comparable with those expressed by wild-type virus-infected Vero cells (data not shown). Furthermore, the absence of the 30-kDa protein in hr81-2-infected cells was not the result of lower overall expression from the UL15 gene since the 59-kDa truncated UL15 protein was still expressed at significant levels ( Fig. 3A and B, lane 4) . This observation has two implications. First, the presence of the 30-kDa version and the absence of the 81-kDa version of the UL15 protein in hr81-1-infected cells indicates that the 30-kDa protein is not likely to be a proteolytic breakdown product of the 81-kDa protein; it may be translated from an internal in-frame methionine downstream of residue 153 of UL15 where the ICP6::lacZ cassette is inserted (see Discussion). Second, the 30-kDa version of UL15 is unable to functionally substitute for the 81-kDa full-length UL15 protein, based on the growth phenotype of hr81-1. Figure 3C shows that the preimmune serum failed to detect either the 81-or 30-kDa band in infected or transfected cell extracts, confirming that both bands detected by the ␣-UL15 antibody are authentic UL15 gene products rather than nonspecific cross-reacting proteins. Although the origin of the 30-kDa protein is not clear, we tentatively designate it UL15.5 (see Discussion). In summary, we conclude that the full-length UL15 protein is essential for viral growth and that its functions cannot be substituted by the 59-kDa C-terminally truncated UL15 protein expressed by hr81-2 or the 30-kDa UL15.5 protein expressed by hr81-1.
hr81-1 and hr81-2 are defective in DNA cleavage while retaining the ability to synthesize viral DNA. The temperaturesensitive mutant of UL15 (ts66.4) is defective in DNA cleavage and packaging at the nonpermissive temperature (6, 44) . hr81-1-or hr81-2-infected Vero cells exhibit wild-type levels of viral DNA synthesis, as assessed by dot blot hybridization (data not shown). To confirm that UL15 is required for the viral DNA cleavage, cells infected with hr81-1 or hr81-2 were examined for the presence of free genomic termini. Total DNA from Vero or M-3 cells infected with KOS, hr81-1, or hr81-2 was digested with BamHI and subjected to Southern blot hybridization with a BamHI SQ-specific probe as described in the legend to Fig. 4 . This probe specifically hybridizes to both terminal BamHI S and Q fragments as well as junction BamHI SQ fragments. The levels of SQ junction fragments present in hr81-1-and hr81-2-infected cells are similar to those in KOSinfected cells (Fig. 4, lanes 2 to 4) , confirming that the UL15 mutants were capable of wild-type levels of DNA replication. However, S and Q terminal fragments were absent in both hr81-1-and hr81-2-infected Vero cells, while these terminal fragments were readily detectable in KOS-infected Vero cells as well as in hr81-1-or hr81-2-infected M-3 cells (Fig. 4 , lanes 2 and 6 to 8), indicating that UL15 mutant viruses were unable to cleave viral DNA concatemers into monomers to generate free viral genomic termini under nonpermissive conditions.
The DNA cleavage defects in hr81-1 and hr81-2 were confirmed by analyzing the structure of viral DNA which accumulates in KOS-and UL15 mutant-infected cells. Viral DNA replication results in the accumulation of concatemeric DNA intermediates, which are subsequently cleaved into mature monomeric genomes. PFGE of DNA from HSV-infected cells results in the separation of viral DNA into two bands, one which does not enter the gel and represents replicating DNA intermediates (well DNA) and one which migrates as a 152-kb genome-length DNA (35, 48, 60) . Total DNA from Vero or M-3 cells infected with either KOS, hr81-1, or hr81-2 was subjected to PFGE and subsequently analyzed by Southern blot using the UL15 cDNA fragment as a probe. DNA from KOS-infected Vero cells as well as UL15 mutant-or KOSinfected M-3 cells contains both replicating well DNA and monomeric DNA (Fig. 5, lanes 2 and 6 to 8) . However, DNA from hr81-1 and hr81-2-infected Vero cells contains only well DNA (Fig. 5, lanes 3 and 4) . The absence of 152-kb genomelength viral DNA in hr81-1-and hr81-2-infected Vero cells indicates that inactivation of the UL15 gene results in the failure to cleave DNA concatemers into mature monomeric genomes. The comparable amounts of viral DNA detected in KOS-, hr81-1-, and hr81-2-infected Vero cells (Fig. 5, lanes 2 to  4) is again in agreement with the conclusion that UL15 is not required for viral DNA synthesis.
hr81-1 and hr81-2 are defective in DNA packaging. To assess the ability of hr81-1 and hr81-2 to encapsidate DNA, DNase I-resistant DNA from infected cells was measured. DNase I treatment would be expected to degrade all DNA in infected cells except for encapsidated viral DNA protected by capsids. DNase I-protected DNA from Vero and M-3 cells infected with KOS or UL15 mutants was prepared as described in the legend to Fig. 6 and analyzed by Southern blot using the 32 P-labeled BamHI SQ fragment as a probe. Figure 6 shows that DNase I-resistant S and Q terminal fragments were observed in KOS-infected Vero cells and in KOS-or UL15 mutant-infected M-3 cells, indicating that the viral monomeric DNA was encapsidated efficiently (Fig. 6, lanes 2 and 6 to 8) . In contrast, DNA from hr81-1 and hr81-2-infected Vero cells was completely degraded upon DNase I treatment (Fig. 6,  lanes 3 and 4) , suggesting that DNA packaging is defective in these two UL15 mutants. In summary, these results suggest that the UL15 gene is essential for both cleavage and packaging of viral DNA.
hr81-1 and hr81-2 are capable of DNA inversion. During viral DNA replication, the two unique sequences (U L and U S ) invert relative to one another, resulting in four types of viral monomeric isomers (28) . It has been suggested that genomic inversion, a result of a recombination event between the inverted repeats flanking the U L and U S sequences, may be stimulated by the presence of free termini generated by DNA cleavage and packaging (53) . Therefore, we decided to assess genomic inversion in UL15 mutants incapable of DNA cleavage and packaging to see whether the terminal ends generated by this mechanism are essential for inversion. The inversion event can be assessed by examining the restriction pattern of replicating well DNA. For instance, as diagrammed in Fig. 7 , digestion with SpeI, which cleaves once per monomer unit, would be expected to release bands of 118, 152, and 186 kb from the replicating intermediate had the inversion event occurred. Vero cells were infected with UL15 mutant viruses for various times, and well DNA was isolated, digested with SpeI, and analyzed by Southern blotting as described in the legend to Fig. 8 . Using the 32 P-labeled BamHI SQ fragment as a probe, the predicted 118-, 152-, and 186-kb bands were detected in KOS-infected as well as in hr81-1-and hr81-2-infected Vero cells as early as at 6 h postinfection (Fig. 8, lanes 4 to 6) . At each of the times tested (from 3 to 15 h), the levels of three isomer bands in hr81-1-and hr81-2-infected cells were comparable to those in KOS-infected cells and increased with time. These results clearly indicate that DNA inversion occurs in UL15 mutants as efficiently as in the wild-type virus. Lamberti and Weller demonstrated that in a mutant virus defective in UL6, another gene required for DNA cleavage and packaging, DNA inversion occurs normally as well (32) . Taken together, these results indicate that recombination and genomic inversion is likely linked to DNA replication rather than to DNA cleavage and packaging, which is in agreement with the model proposed by Sarisky and Weber (47) .
In this experiment, well DNA was also analyzed for the presence of free termini. It has been reported that wild-type well DNA contains only one type of free genomic termini corresponding to the U L portion of the HSV-1 genome (35, 60) . Furthermore, the U L termini can be released as either an FIG. 5 . UL15 mutants fail to process concatemeric replicating DNA to monomeric viral genomes. Vero or M-3 cells were infected with the indicated virus at an MOI of 5 PFU per cell at 37ЊC. At 18 h postinfection, 7.5 ϫ 10 5 infected cells were suspended in low-melting-point agarose gel blocks, lysed in situ, subjected to PFGE as described previously (35) , and analyzed by Southern blot hybridization using the 32 P-labeled AflII/MluI UL15 cDNA fragment as a probe. 80-kb or a 46-kb band upon SpeI digestion, depending on the orientation of the terminal U L arm as diagrammed in Fig. 7 , and these two bands were found to hybridize with a U L terminus-specific probe but not with a U S -specific probe in Southern blot analysis (32, 60) . In Fig. 8 , two extra bands, corresponding to the 80-and 46-kb SpeI U L -terminal fragments, were detected in the SpeI-treated wild-type well DNA as early as at 9 h postinfection as reported previously, while they were absent in the SpeI-treated well DNA from either hr81-1-or hr81-2-infected cells at all times tested. The presence of U L termini in wild-type replicating DNA led Zhang et al. to propose that these free termini may result either from the initiation and termination of DNA replication or from the cleavage/packaging process (60) . The absence of these two bands in the SpeItreated well DNA from hr81-1-or hr81-2-infected cells reported in this paper, together with the observation by Lamberti and Weller that U L termini were also absent in SpeI-treated well DNA from the UL6 mutant (32) , suggests that these free U L termini present in the replicating concatemeric DNA intermediates are products of DNA cleavage and packaging rather than DNA replication.
Analysis of capsid formation in hr81-1 and hr81-2. Herpesvirus-infected cells contain three types of capsid structures (A, B, and C), as identified by sucrose gradient velocity centrifugation. It was reported that only B-type capsids were found in Vero cells infected with mutants defective in cleavage and packaging (1-3, 32, 42, 52, 55) . The absence of A-and C-type capsids suggests that DNA packaging is not even attempted. In contrast, infection of Vero cells with a mutant defective for viral alkaline nuclease (UL12) results in the appearance of B capsids, an increased abundance of A capsids, and few C capsids. This result suggests that packaging was attempted but was either interrupted or aborted (49) . In this study, lysates of Vero cells infected with KOS, hr81-1, or hr81-2 were subjected to 15 to 50% sucrose gradient centrifugation as described in Materials and Methods. In KOS-infected Vero cells, all three capsid bands, A, B, and C, were clearly observed (Fig. 9, lane 1) . However, in both hr81-1-and hr81-2-infected cells, only B-type capsids were seen (Fig. 9, lanes 2 and 3) . The absence of A and C capsids in hr81-1-and hr81-2-infected Vero cells suggests that, unlike the UL12 mutant, in which DNA encapsidation is attempted but aborted, both UL15 mutants were defective at (lanes 1 to 3) , 6 h (lanes 4 to 6), 9 h (lanes 7 to 9), 12 h (lanes 10 to 12), and 15 h (lanes 13 to 15). Well DNA was twice purified away from monomeric DNA as described previously (35) , digested with SpeI in situ, subjected to PFGE, and analyzed by Southern blot hybridization using the 32 an earlier stage, in which DNA encapsidation has not even been attempted.
DISCUSSION
In this study, permissive cells were constructed in order to isolate and propagate HSV-1 mutants hr81-1 and hr81-2 containing the disrupted UL15 gene in which the ICP6::lacZ mutagenic cassette was inserted in exon 1 and exon 2, respectively. hr81-1 and hr81-2 can grow and form plaques on UL15-permissive cells but not on Vero cells, confirming that UL15 is an essential gene for viral growth. Both mutants are defective in DNA cleavage and packaging, and they accumulate only Btype capsids although they still retain the ability to synthesize wild-type levels of DNA. Only cells containing the UL15 gene either stably as in permissive cell lines or transiently as in the transient complementation assay are able to support the growth of hr81-1 and hr81-2, indicating that the phenotypes of UL15 mutant viruses are due to loss of UL15 function. Our results are consistent with those obtained from studies of the UL15 temperature-sensitive mutant ts66.4 (6, 44) .
The wild-type virus synthesizes two proteins with molecular masses of 81 and 30 kDa, detected by Western blot analysis using a polyclonal antibody raised against the UL15 exon 2 sequence. These results confirm those of Baines et al. for assays using an independently isolated UL15 antibody (6) . Furthermore, a C-terminally truncated derivative of the UL15 protein expressed in hr81-2-infected cells was not able to support viral growth, indicating that the C-terminal 226 aa are essential for UL15 function. Interestingly, hr81-1 was able to synthesize the 30-kDa protein but not the 81-kDa UL15 protein. This result indicates that the 30-kDa protein is a separate translation product rather than a degradation product of the full-length 81-kDa UL15 protein. Analysis of the UL15 protein sequence reveals five internal methionines situated at amino acid residues 370, 418, 443, 460, and 500, which, if used for initiation, would encode proteins with predicted molecular masses of 40, 34, 32, 30 , and 25 kDa, respectively; methionine residues 370 and 443 appear to be in a more optimal context for translation than the other three (31). Costa et al. have identified a 2.7-kb mRNA in the UL15 region which presumably encodes the 81-kDa protein; however, two smaller mRNAs which may have been generated either from independent promoters or by alternative splicing events were observed (15) . It is possible that one of these smaller mRNAs encodes the 30-kDa protein; alternatively, the protein may be translated from the 2.7-kb mRNA, using an internal methionine as a start codon. In this paper, we have tentatively designated this 30-kDa protein as UL15.5.
Although our results indicate that UL15 is essential for viral growth and for DNA cleavage and packaging, its precise role in these processes is still unknown. It has been speculated that the UL15 protein may have a terminase function, based on its homology with the large subunit of T4 terminase complex (gp17) (17) . For most dsDNA bacteriophages, the terminase is composed of two subunits, a 10-to 25-kDa low-molecular-mass protein and a 60-to 75-kDa high-molecular-mass protein, for instance, gp16 and gp17 of T4, gp18 and gp19 of T3, and gpA and gpNu1 of lambda. Large subunits of the terminase usually possess prohead binding and DNA-dependent ATPase activities while the small subunits exhibit sequence-specific DNA binding activities (10, 26) . Furthermore, in these dsDNA phages, genes for two subunits are often situated adjacent to each other in the genome. In the HSV-1 UL15 gene region, all five possible start codons for translation of UL15.5 are situated in UL15 exon 2 and downstream of the potential ATP binding site (GKT [amino acid residues 263 to 265] and DE [amino acid residues 356 to 357]), suggesting that the UL15.5 protein may not have ATP binding activity. It is possible that the UL15.5 protein acts as the small subunit of the terminase. Alternatively, it is possible that another viral protein such as one of the other cleavage and packaging proteins performs this function or that the subunit structure of the HSV terminase is unlike that of the dsDNA bacteriophages.
Since DNA cleavage and packaging are biologically linked with capsid formation, it is expected that some DNA cleavage/ packaging proteins may interact with capsids in vivo. It has been reported that UL6 is present stably in all three types of capsids and mature virion particles and that UL25 is associated with purified HSV-1 virions as well (4, 33, 41) . Preliminary immunoblot analysis reveals that the full-length 81-kDa UL15 protein expressed in KOS-infected cells is associated with B capsids (data not shown). Thus, at least three minor-capsid proteins, UL6, UL15, and UL25, have also been implicated in cleavage and packaging, although their roles are not clear. In dsDNA bacteriophage systems, terminase has been found to interact with proheads. The finding of UL15 in B capsids is consistent with its putative function as the HSV-1 terminase. In addition, by analogy to dsDNA bacteriophage systems, if there is a unique portal vertex, it is intriguing to speculate that some of the minor-capsid components may be part of this structure. Alternatively, herpesviruses may utilize a different DNA packaging mechanism which does not require the presence of a unique portal.
The reagents generated in this study will facilitate the further functional analysis of the UL15 gene. The availability of UL15-permissive cell lines and ICP6::lacZ insertional mutants which are capable of expressing blue color in the presence of X-Gal will facilitate the isolation of viruses bearing subtle site-specific mutations. The null background of UL15 insertional mutants will allow us to develop biochemical assays in vitro and to carry out in vivo complementation assays for the detailed assessment of the functions of individual domains within the UL15 gene.
